[Sol Drops Below $70, 24-Hour Loss Expands To 23%] February 6Th, According To Htx Market Data, Sol Fell Below $70, With A 24-Hour Decline Expanding To 23%

Dollar/Yen Down 0.24% At 156.70

Eurostoxx 50 Futures Fall 0.9%, DAX Futures Down 0.8%

Bitcoin Extends Decline, Now Down 3.5%, Ether Falls 2.7%

[Bnb Drops Below $600] February 6Th, According To Htx Market Data, Bnb Fell Below $600, Now Down To $598, With A 24-Hour Decline Expanding To 14.47%

Two-Year US Treasury Yield Down 2.4 Bps

10-Year US Treasury Yield Down 3 Bps

Stocks Related To Weight Loss Drugs Generally Closed Lower, With Viking Therapeutics Down 11.06%, Shuodi Bio Down 9.91%, Novo Nordisk Adr Down 8.16%, Eli Lilly Down 7.79%, And Hims & Hers, A Budget-friendly Pharmaceutical Company That Produces The Knock-off Novo Nordisk Weight Loss Drug Wegovy, Down 3.77%

Yield On 10-Year Japanese Government Bond Falls 2.5 Basis Points To 2.200%

Bitcoin Reverses Earlier Gain, Down 1.9%, Ether Falls 2.4%

The Nasdaq Biotechnology Index Closed Down 2%, With Component Stocks Jyong Biotech Down 20.95%, Bridgebio Pharma Down 15.21%, Sionna Therapeutics Down 15.12%, Abcellera Biologics Down 14.98%, And Editas Medicine Down 14.62%. Gilead Sciences, However, Performed Relatively Well, Closing Up 2.15%, With Silence Therapeutics Up 5.12%, Erasca Up 5.69%, And Phibro Animal Health Up 22.02%